OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.190
-0.020 (-0.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
OncoCyte Employees
As of December 31, 2023, OncoCyte had 46 total employees, including 43 full-time and 3 part-time employees. The number of employees decreased by 30 or -39.47% compared to the previous year.
Employees
46
Change (1Y)
-30
Growth (1Y)
-39.47%
Revenue / Employee
$15,413
Profits / Employee
-$948,043
Market Cap
36.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enzo Biochem | 136 |
Spectral AI | 78 |
SAB Biotherapeutics | 57 |
AN2 Therapeutics | 41 |
Envoy Medical | 34 |
Elevation Oncology | 29 |
Aileron Therapeutics | 15 |
BioVie | 14 |
OCX News
- 5 weeks ago - OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 - GlobeNewsWire
- 2 months ago - Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles - GlobeNewsWire
- 4 months ago - OncoCyte Corporation (OCX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move - GlobeNewsWire
- 7 months ago - Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine - GlobeNewsWire
- 7 months ago - OncoCyte Corporation (OCX) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Oncocyte Reports First Quarter 2024 Financial Results - GlobeNewsWire